Literature DB >> 10980699

Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase.

A K Howe1, R L Juliano.   

Abstract

Activation of the canonical mitogen-activated protein kinase (MAPK) cascade by soluble mitogens is blocked in non-adherent cells. It is also blocked in cells in which the cAMP-dependent protein kinase (PKA) is activated. Here we show that inhibition of PKA allows anchorage-independent stimulation of the MAPK cascade by growth factors. This effect is transient, and its duration correlates with sustained tyrosine phosphorylation of paxillin and focal-adhesion kinase (FAK) in non-adherent cells. The effect is sensitive to cytochalasin D, implicating the actin cytoskeleton as an important factor in mediating this anchorage-independent signalling. Interestingly, constitutively active p21-activated kinase (PAK) also allows anchorage-independent MAPK signalling. Furthermore, PKA negatively regulates PAK in vivo, and whereas the induction of anchorage-independent signaling resulting from PKA suppression is blocked by dominant negative PAK, it is markedly prolonged by constitutively active PAK. These observations indicate that PKA and PAK are important regulators of anchorage-dependent signal transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980699     DOI: 10.1038/35023536

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  67 in total

Review 1.  Integrins in invasive growth.

Authors:  Cord Brakebusch; Daniel Bouvard; Fabio Stanchi; Takao Sakai; Reinhard Fässler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Suppression of extracellular signal-regulated kinase activity in herpes simplex virus 1-infected cells by the Us3 protein kinase.

Authors:  Uyanga Chuluunbaatar; Richard Roller; Ian Mohr
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.

Authors:  John Fassett; Diane Tobolt; Linda K Hansen
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

4.  CAP interacts with cytoskeletal proteins and regulates adhesion-mediated ERK activation and motility.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Xiaowei Chen; Lisa H Dold; Alan R Saltiel
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

5.  Steady-state increase of cAMP-response element binding protein, Rac, and PAK signaling in presenilin-deficient neurons.

Authors:  Natalie Y Barnes; Jun Shi; Hiroshi Yajima; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurochem       Date:  2007-11-07       Impact factor: 5.372

6.  Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1.

Authors:  Kiran S Nadella; Motoyasu Saji; Naduparambil K Jacob; Emilia Pavel; Matthew D Ringel; Lawrence S Kirschner
Journal:  EMBO Rep       Date:  2009-05-08       Impact factor: 8.807

7.  Integrin-mediated protein kinase A activation at the leading edge of migrating cells.

Authors:  Chinten J Lim; Kristin H Kain; Eugene Tkachenko; Lawrence E Goldfinger; Edgar Gutierrez; Michael D Allen; Alex Groisman; Jin Zhang; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

Review 8.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

9.  Transient dynamic actin cytoskeletal change stimulates the osteoblastic differentiation.

Authors:  Chikahisa Higuchi; Norimasa Nakamura; Hideki Yoshikawa; Kazuyuki Itoh
Journal:  J Bone Miner Metab       Date:  2009-01-30       Impact factor: 2.626

10.  Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

Authors:  Chunling Yi; Erik W Wilker; Michael B Yaffe; Anat Stemmer-Rachamimov; Joseph L Kissil
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.